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Abstract
Background: In human and veterinary medicine, monophasic action potential (MAP) analysis and determination of
local refractory periods by contact electrode technique gives valuable information about local cardiac
electrophysiological properties. It is used to investigate dysrhythmias and the impact of drugs on the myocardium.
Precise measurement of total MAP duration is difficult, therefore the MAP duration is usually determined at a
repolarization level of 90% (APD90). Until now, no studies are published about the feasibility of this technique in
the standing non-sedated horse. In 6 healthy Warmblood horses, on two different days, an 8F quadripolar contact
catheter was passed through a jugular introducer sheath and placed under ultrasound guidance at the level of the
intervenous tubercle or right atrial free wall (RA), and in the right ventricular apex (RV) to record the MAP. The MAP
amplitude and APD90 were measured at a resting sinus rhythm (heart rate of 30-42 bpm) and at pacing cycle
lengths (PCL) of 1000 and 600 ms. The effective refractory period (ERP) was determined at PCL of 1000 and 600 ms.
Results: The overall mean (±SD) APD90 (rest), APD90 (1000) and APD90 (600) were 263 ± 39 ms, 262 ± 41 ms, 236 ±
47 ms for the RA and 467 ± 23 ms, 412 ± 38 ms, 322 ± 29 ms for the RV. The mean ERP1000 and ERP600 were 273 ±
24 ms and 256 ± 22 ms for the RA and 386 ± 40 ms and 293 ± 30 ms for the RV. The measurement variability for the
amplitude, APD90 and ERP measurements in the RA ranged between 36 and 44, 9–22 and 7–8%, respectively. The
measurement variability for the amplitude, APD90 and ERP measurements in the RV ranged between 49 and 66, 6–7
and 10–12%, respectively.
Conclusions: RA and RV MAP duration and ERP can be obtained by a contact electrode in standing non-sedated
horses. The measurement variability varies with catheter location.
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Background
Electrocardiography (ECG) is the most commonly used
technique for recording electrical activity of the myo-
cardium. However, it does not provide precise informa-
tion regarding the dispersion of repolarization or after-
depolarizations since an ECG represents the summation
of electrical activity of many myocardial cells from a
relatively large region of the heart [1]. Local activity can
be recorded by an intracellular action potential (IAP).
However, IAP recordings can only be made in an indi-
vidual cardiac cell and thus can only be performed in
vitro [2]. Monophasic action potential (MAP) has a
smaller magnitude than the IAP but it is proven that
MAP recordings can give highly accurate information
about local atrial or ventricular activation time and the
entire time course of myocardial repolarization [3–11].
The local electrical activity of the in situ beating heart can
be assessed by monophasic action potentials. This wave-
form can be obtained by slight pressure of a contact elec-
trode on the heart muscle and is a result of membrane
potential discharges (depolarisation) and slowly recharges
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(repolarisation). MAPs are useful for investigation of the
electrophysiology of different dysrhythmias (i.e. effects of
cycle length changes and the role of afterdepolarizations
in the genesis of triggered dysrhythmias) and the impact
of drugs (i.e. the effect of antiarrhythmic drugs on the ac-
tion potential duration in the in situ heart) on the heart of
different species [3–11]. The recording of MAP signals in
awake dogs without any interference of anaesthetic drugs is
possible. With this procedure the effect of anaesthetics
drugs on the autonomic nervous system, which has an im-
portant impact on cardiac electrophysiology, can be avoided
[12, 13]. The underlying principles concerning MAP re-
cordings are described elsewhere [1, 14, 15].
Until now, very little information about the possibility of
making MAP recordings in standing horses is available.
This paper describes the technique and the day-to-day
variability of right cardiac MAP recording and refractory
period measurement in the standing non-sedated horse.
Methods
The experimental protocol was approved by the Ethical
Committee of the Faculty of Veterinary Medicine and
the Faculty of Bioscience Engineering at Ghent Univer-
sity (case number EC 2015/85, date of approval 9th of
September, 2015). The horses used in this study are Fac-
ulty owned horses.
The study population consisted of 6 healthy warm-
blood horses (3 geldings, 3 mares) aged (mean ± stand-
ard deviation) 10 ± 5 years, with a body weight of 531 ±
70 kg and a height at the withers of 160 ± 6 cm. Cardio-
vascular or other diseases were excluded based on a
physical examination, a complete blood exam, an echo-
cardiographic examination, a 30-min resting ECG and a
20-min standardized exercise ECG. All horses under-
went the procedure two times on two different days with
at least 2 weeks interval. In each horse an 8.5F introducer
sheath (Introflex, Edwards Lifesciences, Dilbeek, Belgium)
was placed using the Seldinger technique in the lower third
of the jugular vein. An 8F quadripolar contact catheter with
separated recording and pacing electrodes (EasyMap MAP,
Medfact, Lörrach, Germany) was used [3, 5] (Fig. 1). The
catheter was inserted via the introducer sheath and placed
under ultrasound guidance at the level of the intervenous
tubercle (in 9/12 procedures) or at the level of the right
atrial free wall (RA) (in 3/12 procedures) and in the right
ventricular apex (RV) (in all procedures =12/12) (Fig. 2).
The catheter tip was pressed softly against the endocar-
dium. Exact pressure determination against the wall was
not possible with this type of catheter. MAPs were recorded
after placement of the catheter in a position that provided
continuous recordings with a stable amplitude of > 2 mV in
the RA and > 3 mV in the RV, a stable baseline, a sharp
positive phase and an upward convex plateau phase [14].
MAP signal and a surface ECG (base-apex) were recorded
simultaneously using a multichannel recorder (PowerLab
8/35, ADInstruments, Oxford, United Kingdom) with amp-
lifier (Bio Amp and Quad Bridge Amp, ADInstruments,
Oxford, United Kingdom) and digitized on a computer.
Measurements were performed off-line using the ECG ana-
lysis (used for determination of QT interval) and cardiac
action potential peak analysis module of a specialized semi-
automatic data analysis software program (LabChart 8,
ADInstruments, Oxford, United Kingdom). The minimum
peak height detection was set at 1.5 mV and an automatic
resting membrane potential detection was used. The MAP
signals were amplified using a low-pass filter with settings
between 20 and 50 Hz because it reduces noise which re-
sults in a smoother signal. Each MAP curve was checked
separately and only MAPs where the automatic resting
membrane potential was automatically set at the level of
true baseline were used. In every horse, 15 cardiac cycles
were analysed per chamber and per day. The APD90 was
automatically measured by the software as the duration be-
tween the upstroke and 90% repolarization. The amplitude
was measured as the height from baseline to the crest of
the plateau phase. First, measurements were made in sinus
rhythm at rest (non-paced) at a cardiac rate between 30
and 42 beats per minute (bpm). Subsequently, to have a
more stable rhythm and to follow the impact of heart
frequency on action potential characteristics, the
Fig. 1 Illustration of the tip of an 8F quadripolar contact catheter
with separated recording and pacing electrodes
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pacing electrodes of the MAP catheter were connected to
a pacemaker programmer (Medtronic, Jette, Belgium) and
pacing was performed at a pacing cycle length of 1000 and
600 ms to record MAPs at each pacing rate. Finally, atrial
and ventricular effective refractory period (ERP) were de-
termined as previously described [16, 17]. In brief, after
pacing for 2 min with a fixed pacing interval (S1-S1), an
extra stimulus (S2), at two times threshold amplitude, was
introduced with a coupling interval (S1-S2) below the ex-
pected refractory period. The coupling interval was in-
creased in steps of 8 ms until capture of the extra stimulus
occurred (the atrial or ventricular S2 was followed by a P
wave or QRS complex on the surface ECG, respectively).
The longest S1-S2 interval without capture was taken as
the effective refractory period. ERP was always determined
5 times to obtain a mean value. After the procedure, all
catheters were gently removed under ultrasound guidance.
Data analysis
Statistical analyses were performed using dedicated soft-
ware (SPSS Statistics 22.0, SPSS Inc., Chicago, Illinois).
Mean and standard deviation (SD) were calculated from
pooled measurements of all examinations for each horse.
Measurement variability was obtained by comparing the re-
sults of the measurements from day 1 and day 2 in a one-
way repeated measures analysis of variance with the horse
as the unit of repeated measure. The numerical values for
the reported coefficients of variation (CV) were calculated
by dividing the square root of the mean square error (MSE)
by the grand mean, multiplied by 100. The relationship be-
tween QT interval and APD90 was evaluated using a linear
regression model with QT interval, day and horse as pre-
dictors. A value of P < 0.05 was considered significant.
Results
Right atrial (Fig. 3a) and right ventricular (Fig. 3b) MAP
recordings of sufficient quality could be obtained and
analysed in non-sedated standing horses. However, horse
movements, occasionally resulted in loss of contact
requiring MAP catheter repositioning. The total record-
ing time per horse and per day ranged between 35 and
165 min. Catheter positioning was occasionally associated
with self-limiting atrial or ventricular depolarizations which
terminated after slight catheter tip movements. During
atrial ERP measurements, a short episodes of self-limiting
episode of atrial tachycardia was occasionally found and 1
horse showed a 20-min paroxysm of atrial fibrillation.
Ventricular ERP measurements were never associated with
tachyarrhythmias. No complications were observed after
the procedure. Typical right atrial and ventricular MAP
recordings are shown in Fig. 3. All the results of the two
different days are shown in Table 1 and Fig. 4. In 1 horse a
difference of up to 100 ms was observed during VERP1000
measurement. The QT interval was a significant predictor
of APD90 in sinus rhythm (beta 0.604, P < 0.001) and at a
pacing cycle length of 1000 ms (beta − 0.177, P = 0.018),
but not at a pacing cycle length of 600 ms.
Discussion
The present paper describes the technique to determine
right atrial and right ventricular repolarization and
Fig. 2 Ultrasound images of the contact MAP electrode (arrow)
positioned at the level of the intervenous tubercle (IT) in the right
atrium (a), at the level of the right atrial free wall (b) and in the right
ventricular apex (c). RA: right atrium, TV: tricuspid valve, RV: right
ventricle, LV: left ventricle, IVS: interventricular septum
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refractoriness in the standing non-sedated horse. In
humans, dogs, cats and pigs, MAP recordings play an
important role in the investigation of myocardial electro-
physiology under physiological, pathological and pharma-
cological conditions and have a low level of risk [18–21].
However, complications such as sustained dysrhythmias,
movement artefacts or pericardial effusion have been re-
ported [21]. In our study, complications were limited to
some short episodes of ectopic rhythms and 1 short epi-
sode of atrial fibrillation during ERP measurement. The
ERP values in our study were comparable with previously
reported results [17]. The coefficient of variation of the
ERP measurements ranged between 7 and 12% but in one
horse the difference in VERP1000 measurement was >
100 ms. As observed in awake dogs, neck and body move-
ments of the horse occasionally resulted in dislocation of
Fig. 3 Surface electrocardiogram (ECG) with corresponding right atrial (a) and right ventricular (b) monophasic action potential (MAP) at resting
sinus heart rhythm in the standing non-sedated horse
Table 1 Mean ± SD of monophasic action potential amplitude and repolarization level of 90% (APD90), and effective refractory
periods (ERP) measured at rest and at a pacing cycle length of 1000 and 600 ms in the right atrium and right ventricle
Right atrium Right ventricle
Mean ± SD Mean ± SD
Day 1 Day 2 Overall Cv % Day 1 Day 2 Overall CV %
amplitude (rest) (mV) 6.9 ± 1.9 4.4 ± 1.9 5.7 ± 2.3 35.6 9.1 ± 4.3 7.2 ± 3.3 8.1 ± 3.8 49.2
amplitude (1000) (mV) 6.0 ± 2.0 4.0 ± 1.0 5.0 ± 2.0 44.0 7.8 ± 2.6 8.8 ± 5.4 8.3 ± 4.0 58.9
amplitude (600) (mV) 6.0 ± 1.0 6.0 ± 2.0 6.0 ± 2.0 37.3 7.7 ± 2.5 9.7 ± .8 8.7 ± 4.4 65.5
APD90 (rest) (ms) 282 ± 41 244 ± 29 263 ± 39 9.1 464 ± 30 469 ± 15 467 ± 23 6.2
APD90 (1000) (ms) 281 ± 47 243 ± 23 262 ± 41 12.3 399 ± 38 443 ± 24 421 ± 38 7.3
APD90 (600) (ms) 242 ± 17 231 ± 67 236 ± 47 21.6 325 ± 26 319 ± 34 322 ± 29 5.6
ERP1000 (ms) 269 ± 18 277 ± 31 273 ± 24 7.9 401 ± 34 370 ± 43 386 ± 40 11.8
ERP600 (ms) 251 ± 14 261 ± 28 256 ± 22 6.5 295 ± 38 291 ± 23 293 ± 30 9.6
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the catheter and loss of tip pressure increasing recording
time and measurement variability [12]. Due to a more
fixed catheter position in the apex, dislodgement of the
catheter tip was less frequently observed in ventricular
MAP recordings. Probably, some spatial repolarization
differences might also contribute to the measurement
Fig. 4 Graphical illustration of monophasic action potential amplitude (a and d) and repolarization level of 90% (APD90) (b and e), and effective
refractory periods (ERP) (c and f) measured at rest (sinus rhythm: SR) and at a pacing cycle length of 1000 and 600 ms in the right atrium (RA) (a,
b and c) and right ventricle (RV) (d, e and f) in two different days. The median and spread of the value is indicated by a boxplot, with the box
span indicating the middle half of the observations, the line in the box marking the median, and the whiskers indicating the range of
observations. Extreme values were plotted individually at the end of the whiskers
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variability [12, 18]. MAP duration and amplitude can be
variable due to angle differences of the catheter tip relative
to the myocardium, the catheter location and varying
endocardial contact pressures in the beating heart [14, 22].
Prolonged good quality MAP recordings from the same
endocardial site (up to 1 h), as described for awake dogs,
could not be achieved in our horses [13]. Mild sedation or
the use of another type of catheter could have facilitated
the procedure in our study. In humans and sedated dogs,
the MAP amplitude of the atrium and ventricle ranges be-
tween 5 and 50 mV due to a variability in contact pressure
but also due to tissue type and species [12, 14, 22]. The
difference in amplitude between the atrium and the ven-
tricle has partly been explained by the different thickness
of the endocardial tissue beneath the tip of the catheter
[12]. The reason for the species- and tissue-related differ-
ence in MAP amplitude remains unexplained [21]. Intra-
cellular recordings have amplitudes of approximately
120 mV regardless species or tissue dependence [22]. The
MAP amplitude in our horses ranged between 2 and
10 mV for the atrium and between 3 and 16 mV for the
ventricle, which could be related to endocardial properties.
The large size of the equine heart seems to be a large dis-
advantage and also has probably contributed to a less
stable catheter position. The most frequently used filters
with MAP measurements are the low-pass filter and the
high-pass filter. The manuals of the used program advice
to use a low-pass filter since it lets low frequencies pass
and stops high frequencies. This results in a reduction of
noise, it gives a smoother MAP signal. The use of a high
pass filter lets high frequencies pass and remove any
steady component or slow fluctuations from the signal.
This setting is used to stabilize baseline. In this study, a
low pass filter was used to obtain smoother MAP signals.
In addition, each MAP signal was checked manually to
evaluate if the automatic resting membrane potential was
correctly set at the level of baseline.
Study limitations
Despite ultrasonographic guidance, dislocation of the
catheter and changes in contact pressure by the beating
heart and horse movements contributed to the variabil-
ity. Further research is necessary to identify whether re-
peating the measurements in a higher number of horses,
harder pressure on the catheter tip, measurement under
general anaesthesia or using another type of catheter
(with i.e. a spring-steel stylet that is inserted into the
myocardium) results in a lower variability in horses. Also
the influence of spatial differences within right atrium
and right ventricle, and between the left and right heart
should be investigated. In humans, access to the left
heart is possible transseptal or via the arteria femoralis
[23–25]. In horses, access to the left heart might be pos-
sible via the carotid artery or transseptal.
The present study describes the feasibility and meas-
urement variability of MAP recordings and refractory
period measurements with a quadripolar contact cath-
eter in the standing non-sedated horse. Further research
is necessary to evaluate if this MAP recording technique
might be useful to investigate equine dysrhythmias and
the impact of drugs on the myocardium.
Conclusion
RA and RV MAP duration and ERP can be obtained by
a contact electrode in standing non-sedated horses. The
measurement variability varies with catheter location.
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